VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Century Therapeutics, Inc. (IPSC) Total Return Calculator with Dividends Reinvested

Century Therapeutics, Inc.

Popular:

The total return for Century Therapeutics, Inc. (IPSC) stock is +342.70% over the past 12 months. So far it's up 132.16% this year. The 5-year total return is -89.88%, meaning $10,000 invested in IPSC stock 5 years ago would be worth $1,012 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in IPSC 1 year ago, it would be worth $44,423 today — you'd have gained $34,423.

With Dividends Reinvested$44,423+344.23%

Price Only (No DRIP)$44,423+344.23%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in IPSC

1Y$44,270+$34,270 (+342.7%)342.7% CAGR

3Y$7,152-$2,848 (-28.5%)-10.6% CAGR

5Y$1,012-$8,988 (-89.9%)-36.8% CAGR

10Y$1,012-$8,988 (-89.9%)-20.5% CAGR

15Y$1,012-$8,988 (-89.9%)-14.2% CAGR

20Y$1,012-$8,988 (-89.9%)-10.8% CAGR

30Y$1,012-$8,988 (-89.9%)-7.4% CAGR

Century Therapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading IPSC total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+132.16%	—	+132.16%	—	$23,216
1Y	+342.70%	342.70%	+342.70%	—	$44,270
3Y	-28.48%	-10.57%	-28.48%	—	$7,152
5Y	-89.88%	-36.76%	-89.88%	—	$1,012
10Y	-89.88%	-20.47%	-89.88%	—	$1,012
15Y	-89.88%	-14.16%	-89.88%	—	$1,012
20Y	-89.88%	-10.82%	-89.88%	—	$1,012
30Y	-89.88%	-7.35%	-89.88%	—	$1,012

Risk & Highlights

Best Year-4.33%2025

Worst Year-72.25%2024

Max Drawdown-36.98%2026-01-27 → 2026-02-05 · Recovered 2026-03-09

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+133.17%	+133.17%	—	+0.41%	+132.8pp
2025	-4.33%	-4.33%	—	+16.64%	-21.0pp
2024	-72.25%	-72.25%	—	+24.00%	-96.3pp
2023	-33.20%	-33.20%	—	+24.81%	-58.0pp
2022	-67.78%	-67.78%	—	-19.95%	-47.8pp

IPSC outperformed the S&P 500 by 312.33pp over the past year (+342.70% vs +30.37%).

Loading summary...

IPSC Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
IPSCCentury Therapeutics, Inc.	$202M	+2.2%	+132.2%	+342.7%	—	-28.5%	-89.9%	-89.9%
FATEFate Therapeutics, Inc.	$280M	+111.3%	+145.5%	+143.0%	—	-55.4%	-96.8%	+40.5%
NKTRNektar Therapeutics	$1.7B	+9.4%	+92.0%	+818.2%	—	+621.8%	-72.3%	-59.1%
CELCCelcuity Inc.	$5.7B	+13.1%	+30.0%	+1184.0%	—	+1292.0%	+381.6%	+814.7%
IOVAIovance Biotherapeutics, Inc.	$1.3B	+6.9%	+40.9%	+13.4%	—	-49.9%	-87.6%	-34.3%
CRSPCRISPR Therapeutics AG	$5.1B	+5.5%	-2.5%	+53.1%	—	-6.3%	-51.3%	+272.0%
NTLAIntellia Therapeutics, Inc.	$1.6B	+1.2%	+48.9%	+88.1%	—	-68.3%	-79.8%	-42.9%
BEAMBeam Therapeutics Inc.	$3.2B	+28.5%	+16.0%	+93.9%	—	-5.6%	-55.6%	+67.8%
EDITEditas Medicine, Inc.	$297M	+10.6%	+47.8%	+127.8%	—	-68.5%	-91.1%	-90.0%
ALNYAlnylam Pharmaceuticals, Inc.	$39.5B	-7.4%	-26.1%	+7.0%	—	+40.9%	+125.4%	+411.9%
ILMNIllumina, Inc.	$21.1B	+9.7%	+3.2%	+81.7%	—	-27.1%	-62.8%	+0.7%

Compare:IPSC vs FATE IPSC vs NKTR IPSC vs CELC IPSC vs FATE vs NKTR

About IPSC Dividend Returns

Century Therapeutics, Inc. (IPSC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of IPSC over the past year?

Century Therapeutics, Inc. (IPSC) delivered a return of 342.70% over the past year. Since IPSC does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in IPSC be worth today?

A $10,000 investment in Century Therapeutics, Inc. one year ago would be worth $44,270 today, representing a gain of $34,270.

Q3Does IPSC pay dividends?

Century Therapeutics, Inc. (IPSC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For IPSC, the total return equals the price-only return.

Q4Did IPSC beat the S&P 500?

Yes, Century Therapeutics, Inc. (IPSC) outperformed the S&P 500 by 312.33 percentage points over the past year. IPSC delivered a total return of 342.70%, compared to the S&P 500's 30.37%. This 312.33pp alpha means investors in IPSC earned more than a passive S&P 500 index fund.

Q5What is IPSC's worst drawdown?

Century Therapeutics, Inc. (IPSC) experienced a maximum drawdown of -36.98% over the past year, declining from its peak on 2026-01-27 to its trough on 2026-02-05. The stock recovered to its prior peak by 2026-03-09. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is IPSC's long-term total return over 10, 20, or 30 years?

Here are Century Therapeutics, Inc. (IPSC)'s long-term returns with dividends reinvested. Over 10 years, the total return is -89.9% (-20.5% CAGR) — $10,000 would have grown to $1,012. Over 20 years: -89.9% total return (-10.8% CAGR) — $10,000 → $1,012. Over 30 years: -89.9% total return (-7.4% CAGR) — $10,000 → $1,012. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was IPSC's best and worst year?

Century Therapeutics, Inc.'s best calendar year was 2025 with a total return of -4.3%. Its worst year was 2024 with a total return of -72.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 67.9 percentage points.